PDA + GHK-Cu protocol: PDA: 500 mcg subcutaneous or oral, once daily GHK-Cu: Per standard dosing guidelines (varies by administration route) Duration: 4 to 8 weeks PDA + SS-31 (Elamipretide) For researchers focused on mitochondrial health and cellular energy, combining penta deca peptide arginate with SS-31 creates a protocol that addresses tissue repair from both structural and energetic perspectives
The agencies have not reached any new conclusions about safety risks of the incretin mimetics, although they have expressed that the totality of the data that have been reviewed provides reassurance
If your condition allows, try to eat regular meals with protein and complex carbohydrates to support your metabolism
(PubMed) Orhan Kilic B, Kilic S, Sahin Eroglu E, Gul E, Belen Apak FB
GLP-1 appetite suppression is stronger and glucagon effects continue to scale with dose
Injecting these substances carries real safety risks